Most Clicked StoriesMore >


Study finds pioglitazone safe, effective for patients with diabetes, NASH

DiabetesPro SmartBrief | Jun 22, 2016

Fifty-eight percent of patients with prediabetes or type 2 diabetes and nonalcoholic steatohepatitis who took pioglitazone for 18 months had an at least two-point reduction in the nonalcoholic fatty liver disease activity score without worsening of fibrosis, while 51% had NASH resolution, according to a study in the Annals of Internal Medicine. The findings, based on 101 patients, also showed a correlation between pioglitazone treatment and improved histologic scores, adipose tissue, hepatic and muscle insulin sensitivity, and reduced hepatic triglyceride content. PhysiciansBriefing.com (06/21)


Heart attack patients with diabetes at 50% increased risk of dying, study finds

DiabetesPro SmartBrief | Jun 23, 2016

Study shows specific nutrition plan is more beneficial for diabetes patients

DiabetesPro SmartBrief | Jun 23, 2016

Gluten-free diet improves cholesterol in children with diabetes, celiac disease

DiabetesPro SmartBrief | Jun 21, 2016

FDA panel to debate on cardiac risk improvement with Jardiance

DiabetesPro SmartBrief | Jun 27, 2016

Children with autoantibody reversion remain at increased risk for diabetes

DiabetesPro SmartBrief | Jun 22, 2016

Healthy lifestyle can reduce cancer risk up to 45%, data show

DiabetesPro SmartBrief | Jun 27, 2016

Higher A1C variability ups complication risks in teens with diabetes

DiabetesPro SmartBrief | Jun 21, 2016

Study finds age may affect impact of exercise on cell health

DiabetesPro SmartBrief | Jun 21, 2016

Free CME/CE Webcast: Standards of Medical Care 2016

DiabetesPro SmartBrief | Jun 21, 2016


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Pathway to Stop Diabetes Call for Nominations Now Open!

DiabetesPro SmartBrief | Jun 28, 2016

Are you a Professional Member?

DiabetesPro SmartBrief | Jun 27, 2016

Free CME/CE Opportunity -- Self-Assessment Program on the Management of Diabetes in Children

DiabetesPro SmartBrief | Jun 24, 2016

Only 1 day left: our goal is within reach!

DiabetesPro SmartBrief | Jun 23, 2016

Free CME/CE opportunity -- Self-Assessment Program on Cardiometabolic Risk

DiabetesPro SmartBrief | Jun 23, 2016




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.